6Y1.F INTEGRUM AB B
- Market cap
- EUR 18.5M
- P/E
- -
- P/B
- 1.15x
- ROE
- 2.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jul 2026.
Is 6Y1.F undervalued?
Graham numberThe Graham number of INTEGRUM AB B cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
INTEGRUM AB B fundamental analysis
No fundamental analysis for INTEGRUM AB B yet.
INTEGRUM AB B stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About INTEGRUM AB B
Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads. It also provides Neuromotus, a technolo…
Full company profileINTEGRUM AB B financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jul 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
INTEGRUM AB B annual financial statements (SEK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 55.7M | 74.3M | 104M | 91.1M | 91.4M | 121M |
| Gross Profit | 46.6M | 60.8M | 91.3M | 75.4M | 63.2M | 127M |
| Operating Income | -7.45M | -25.3M | 691K | -41.6M | -51.5M | 8.99M |
| EBITDA | - | -20.4M | 8.76M | -35.2M | -34.3M | 15.4M |
| Net Income | 21.3M | -16.2M | 4.03M | -30.8M | -46.3M | 3.49M |
| EPS | 1.16 | -0.87 | 0.21 | -1.43 | -1.74 | 0.13 |
| Balance Sheet | ||||||
| Total Assets | 180M | 165M | 165M | 203M | 204M | 199M |
| Total Liabilities | 20.7M | 21.6M | 22.1M | 25.4M | 31.6M | 25.0M |
| Shareholders' Equity | 160M | 144M | 143M | 178M | 172M | 174M |
| Cash & Short-term Investments | 75.3M | 41.9M | 16.9M | 39.6M | 19.1M | 15.0M |
| Cash Flow | ||||||
| Operating Cash Flow | -20.3M | -25.1M | -12.7M | -38.3M | -41.0M | -8.64M |
| Capital Expenditure | 29.3M | 11.4M | 11.6M | 11.9M | 16.9M | 7.94M |
| Free Cash Flow | -49.5M | -36.5M | -24.4M | -50.2M | -58.0M | -16.6M |
| Ratios | ||||||
| ROE | 13.3% | -11.3% | 2.8% | -17.3% | -26.9% | 2.0% |
| ROA | 11.8% | -9.8% | 2.4% | -15.2% | -22.8% | 1.8% |
| Net Profit Margin | 38.2% | -21.8% | 3.9% | -33.8% | -50.7% | 2.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
INTEGRUM AB B dividends
INTEGRUM AB B has not paid dividends in the last 5 fiscal years.
Who owns INTEGRUM AB B
- Insiders 25.98%
- Institutions 18.59%
- Public & others 55.44%
- Shares outstanding 26.0M
- Free float 16.1M
INTEGRUM AB B company profile
- Company name
- INTEGRUM AB B
- Ticker
- 6Y1.F
- ISIN
- SE0009807266
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 33
- Fiscal year end
- April
- Address
- Gemenskapens gata 9, Mölndal, Sweden, 431 53
- Phone
- 46 3 17 60 10 60
- Website
- integrum.se
About INTEGRUM AB B
Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads. It also provides Neuromotus, a technology that is used for therapy to reduce phantom limb pain after an amputation. It sells its implant systems to hospitals, clinics, and orthopedists worldwide. The company was incorporated in 1990 and is headquartered in Mölndal, Sweden.
INTEGRUM AB B management
6- Dr. Rickard BranemarkFounder, Owner, Chief Medical & Scientific Officer and Chairman of the Board · born 1960
- Mr. Martin HillstenChief Executive Officer · born 1978
- Ms. Louise WahlinChief Financial Officer
- Annika FahlénChief Compliance & Development Officer
- Mr. Per M. NilssonChief Supply & IT Officer
- Ms. Anna-Tove BranemarkChief Executive Officer of Integrum Inc. · born 1967